Levin Gabriel, Ramirez Pedro T, Wright Jason D, Slomovitz Brian M, Hamilton Kacey M, Schneyer Rebecca J, Barnajian Moshe, Nasseri Yosef, Siedhoff Matthew T, Wright Kelly N, Meyer Raanan
Division of Gynecologic Oncology, Jewish General Hospital, McGill University, Quebec, Canada.
Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, TX.
Am J Obstet Gynecol. 2025 Feb;232(2):208.e1-208.e11. doi: 10.1016/j.ajog.2024.08.008. Epub 2024 Aug 14.
The Laparoscopic Approach to Cervical Cancer study results revolutionized our understanding of the best surgical management for this disease. After its publication, the guidelines state that the standard and recommended approach for radical hysterectomy is an open abdominal approach. Nevertheless, the effect of the Laparoscopic Approach to Cervical Cancer trial on real-world changes in the surgical approach to radical hysterectomy remains elusive.
This study aimed to investigate the trends and routes of radical hysterectomy and to evaluate postoperative complication rates before and after the Laparoscopic Approach to Cervical Cancer trial (2018).
The National Surgical Quality Improvement Program registry was used to examine radical hysterectomy for cervical cancer performed between 2012 and 2022. This study excluded vaginal radical hysterectomies and simple hysterectomies. The primary outcome measures were the trends in the route of surgery (minimally invasive surgery vs laparotomy) and surgical complication rates, stratified by periods before and after the publication of the Laparoscopic Approach to Cervical Cancer trial in 2018 (2012-2017 vs 2019-2022). The secondary outcome measure was major complications associated specifically with the different routes of surgery.
Of the 3611 patients included, 2080 (57.6%) underwent laparotomy, and 1531 (42.4%) underwent minimally invasive radical hysterectomy. There was a significant increase in the minimally invasive surgery approach from 2012 to 2017 (45.6% in minimally invasive surgery in 2012 to 75.3% in minimally invasive surgery in 2017; P<.01) and a significant decrease in minimally invasive surgery from 2018 to 2022 (50.4% in minimally invasive surgery in 2018 to 11.4% in minimally invasive surgery in 2022; P<.001). The rate of minor complications was lower in the period before the Laparoscopic Approach to Cervical Cancer trial than after the trial (317 [16.9%] vs 288 [21.3%], respectively; P=.002). The major complication rates were similar before and after the Laparoscopic Approach to Cervical Cancer trial (139 [7.4%] vs 78 [5.8%], respectively; P=.26). The rates of blood transfusions and superficial surgical site infections were lower in the period before the Laparoscopic Approach to Cervical Cancer trial than in the period after the trial (137 [7.3%] vs 133 [9.8%] [P=.012] and 20 [1.1%] vs 53 [3.9%] [P<.001], respectively). In a comparison of minimally invasive surgery vs laparotomy radical hysterectomy during the entire study period, patients in the minimally invasive surgery group had lower rates of minor complications than in those in the laparotomy group (190 [12.4%] vs 472 [22.7%], respectively; P<.001), and the rates of major complications were similar in both groups (100 [6.5%] in the minimally invasive surgery group vs 139 [6.7%] in the laparotomy group; P=.89). In a specific complications analysis, the rates of blood transfusion and superficial surgical site infections were lower in the minimally invasive surgery group than in the laparotomy group (2.4% vs 12.7% and 0.6% vs 3.4%, respectively; P<.001; for both comparisons), and the rate of deep incisional surgical site infections was lower in the minimally invasive surgery group than in the laparotomy group (0.2% vs 0.7%, respectively; P=.048). In the multiple logistic regression analysis, the route of radical hysterectomy was not independently associated with the occurrence of major complications (adjusted odds ratio, 1.02; 95% confidence interval, 0.63-1.65).
Although the proportion of minimally invasive radical hysterectomies decreased abruptly after the Laparoscopic Approach to Cervical Cancer trial, there was no change in the rate of major postoperative complications. In addition, the hysterectomy route was not associated with major postoperative complications.
宫颈癌腹腔镜手术研究结果彻底改变了我们对该病最佳手术治疗方式的理解。该研究结果发表后,指南指出根治性子宫切除术的标准及推荐术式为开腹手术。然而,宫颈癌腹腔镜手术试验对根治性子宫切除术实际手术方式变化的影响仍不明确。
本研究旨在调查根治性子宫切除术的趋势和路径,并评估宫颈癌腹腔镜手术试验(2018年)前后的术后并发症发生率。
利用国家外科质量改进计划登记处的数据,对2012年至2022年间进行的宫颈癌根治性子宫切除术进行研究。本研究排除了经阴道根治性子宫切除术和单纯子宫切除术。主要观察指标为手术路径(微创手术与开腹手术)的趋势及手术并发症发生率,按2018年宫颈癌腹腔镜手术试验发表前后的时期进行分层(2012 - 2017年与2019 - 2022年)。次要观察指标为与不同手术路径相关的主要并发症。
纳入的3611例患者中,2080例(57.6%)接受了开腹手术,1531例(42.4%)接受了微创根治性子宫切除术。2012年至2017年微创手术方式显著增加(从微创手术2012年的45.6%增加至2017年的75.3%;P <.01),2018年至2022年微创手术显著减少(从微创手术2018年的50.4%降至2022年的11.4%;P <.001)。宫颈癌腹腔镜手术试验前的轻微并发症发生率低于试验后(分别为317例[16.9%]和288例[21.3%];P =.002)。宫颈癌腹腔镜手术试验前后的主要并发症发生率相似(分别为139例[7.4%]和78例[5.8%];P =.26)。宫颈癌腹腔镜手术试验前的输血率和浅表手术部位感染率低于试验后(分别为137例[7.3%]和133例[9.8%][P =.012]以及20例[1.1%]和53例[3.9%][P <.001])。在整个研究期间,比较微创与开腹根治性子宫切除术,微创手术组的轻微并发症发生率低于开腹手术组(分别为190例[12.4%]和472例[